TCG Crossover Management, LLC
+127.89%
Rentabilidad a 3 meses
$10.160
+0.010 (+0.10%)Al cierre
Research Alliance Corporation III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination.
Research Alliance Corp III (RACC) is currently not a strong buy. The stock is trading at $10.10, significantly below its 52-week high of $33.50, indicating a potential for recovery but also a substantial risk. The RSI is at 37.048, suggesting it is nearing oversold territory, but the lack of positive momentum is concerning. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the recent net income shows volatility with a loss of $65,249 in Q1 2026 followed by a gain of $54,050 in Q2 2026. The main risk is the current ratio of 17.30, which, while indicating strong liquidity, follows a period of much lower ratios, suggesting instability. Overall, while there are potential upsides, the current indicators do not strongly support a buy at this moment.

Three IPOs and Seven SPACs Priced This Week

Research Alliance Corporation III Prices IPO at $10 per Share

Research Alliance III Raises $75 Million for Healthcare SPAC

Research Alliance Corporation III Announces IPO Pricing
Research Alliance Corporation III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination. It operates in the Financials sector.
Research Alliance Corp III (RACC) is currently not a strong buy. The stock is trading at $10.10, significantly below its 52-week high of $33.50, indicating a potential for recovery but also a substantial risk. The RSI is at 37.048, suggesting it is nearing oversold territory, but the lack of positive momentum is concerning. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the recent net income shows volatility with a loss of $65,249 in Q1 2026 followed by a gain of $54,050 in Q2 2026. The main risk is the current ratio of 17.30, which, while indicating strong liquidity, follows a period of much lower ratios, suggesting instability. Overall, while there are potential upsides, the current indicators do not strongly support a buy at this moment.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.